Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies

After adjusting for selection bias inherent in the STAR*D comparison of augment with switch, clinically meaningful differences in the adverse event profiles between these treatment strategies were not observed.